Jaime Monserrat Villatoro

Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

Alberto M. Borobia, Antonio J. Carcas, Mayte Pérez‐Olmeda et al. · The Lancet · 2021 · 384 citations · Full text

A Cohort of Patients with COVID-19 in a Major Teaching Hospital in Europe

Alberto M. Borobia, Antonio J. Carcas, Francisco Arnalich et al. · Journal of Clinical Medicine · 2020 · 289 citations · Full text

A case report of a drug‐induced liver injury (DILI) caused by multiple antidepressants with causality established by the updated Roussel Uclaf causality assessment method (RUCAM) and in vitro testing

Miguel Á. Muñoz, Jaime Monserrat Villatoro, Eva Marín‐Serrano et al. · Clinical Case Reports · 2020 · 17 citations · Full text

A Case-Control of Patients with COVID-19 to Explore the Association of Previous Hospitalisation Use of Medication on the Mortality of COVID-19 Disease: A Propensity Score Matching Analysis

Jaime Monserrat Villatoro, Gina Mejía‐Abril, Lucía Díaz García et al. · Pharmaceuticals · 2022 · 11 citations · Full text

Propensity Score Matching, Pharmacotherapy, Covid-19 Epidemiology +24

Randomised multicentre clinical trial to evaluate voriconazole pre-emptive genotyping strategy in patients with risk of aspergillosis: vorigenipharm study protocol

Jaime Monserrat Villatoro, Irene García-García, David Bueno et al. · BMJ Open · 2020 · 10 citations · Full text